Prostate Cancer Market Insights, Research and Growth Factor till 2033

Posted by Ganesh Shinde on March 3rd, 2023

Future Market Insights predicts that the global prostate cancer market will expand rapidly between 2023 and 2033. It is estimated that worldwide sales of prostate cancer medications are expected to reach nearly US$ 24.7 Billion by 2033. Recent developments in drug development, an increasing number of drugs that have been approved by the FDA, and a high growth rate in the market for hormone-refractory glandular cancer medicines are expected to grow the market in the coming years.

In addition to an aging population, the high disposable income also contributes to the market's growth. Growth will also be driven by rising cancer prevalence rates, the changing fashion habits of the population, an increase in patient awareness, and an increase in demand for non-invasive therapies.

A number of different methods are available to treat this disease, including targeted or biological therapy, chemotherapy, and hormonal therapy. Further new studies are being approved by the FDA for therapies and drugs that are to be marketed in the near future. There is a recent study conducted by Moon Hyung Choi and co-workers suggests the use of pre-biopsy MRIs can effectively prevent unnecessary biopsies in people who have levels of prostate-specific antigen (PSA) in excess of 20 ng/ml.

Competitive Landscape

The availability of oral chemotherapy is one of the major factors driving its demand. Rather than spending exorbitant amounts on medical expenses, preventative measures can be taken. To expand to more complex applications, companies with a wide geographic reach are taking collaborative measures to boost sales, including merging multiple businesses into one to provide more versatile medical products.

Competitors are consolidating their market presence through strategic, profitable partnerships. Companies can use advanced technology more effectively through acquisitions and partnerships. In order to expand their technology horizons, home health clinic companies enter into a number of deals.

Key Players:

  •          Johnson & Johnson Services, Inc
  •          Astellas Pharma Inc.
  •          Eli Lilly and Company
  •          Sanofi
  •          Ipsen Pharma
  •          Bayer AG
  •          AstraZeneca
  •          Valeant Pharmaceuticals International, Inc
  •          Merck & Co., Inc
  •          Pfizer Inc

Get More Insights@ https://www.futuremarketinsights.com/reports/prostate-cancer-market

Key Segments Profiled in the Prostate Cancer Industry Survey

Prostate Cancer Market by Drug Class:

  • Hormonal Prostate Cancer Therapy
    • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
      • Zytiga
      • Gonax
    • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
      • Lupron
      • Zoladex
      • Eligard
      • Decapeptyl
      • Vantas
      • Others
    • Anti-Androgen
      • Xtandi
      • Casodex
  • Prostate Cancer Chemotherapy
    • Taxotere
    • Jevtana
  • Prostate Cancer Immunotherapy
    • Provenge
  • Prostate Cancer Targeted Therapy
    • Xofigo
  • Others Prostate Cancer

Prostate Cancer Market by Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

Like it? Share it!


Ganesh Shinde

About the Author

Ganesh Shinde
Joined: October 27th, 2022
Articles Posted: 868

More by this author